Published ahead of print on August 28, 2003, doi:10.1164/rccm.200212-1514OC
American Journal of Respiratory and Critical Care Medicine Vol 168. pp. 1156-1161, (2003)
© 2003 American Thoracic Society
Defect of Hepatocyte Growth Factor Secretion by Fibroblasts in Idiopathic Pulmonary Fibrosis
Sylvain Marchand-Adam,
Joëlle Marchal,
Murielle Cohen,
Paul Soler,
Bénédicte Gerard,
Yves Castier,
Guy Lesèche,
Dominique Valeyre,
Hervé Mal,
Michel Aubier,
Monique Dehoux and
Bruno Crestani
INSERM unit 408, Faculté Xavier Bichat; and Service de Pneumologie, Laboratoire de Biochimie A, and Laboratoire de Biochimie Hormonale et Génétique, Hôpital Bichat, Assistance Publique-Hôpitaux de Paris, Paris; Service de Chirurgie Thoracique et Vasculaire and Service de Pneumologie, Hôpital Beaujon, Assistance Publique-Hôpitaux de Paris, Clichy; and Service de Pneumologie, Hôpital Avicenne, Bobigny, France
Correspondence and requests for reprints should be addressed to Bruno Crestani, M.D., Service de Pneumologie, Hôpital Bichat, 16 rue Henri Huchard, 75877 Paris Cedex 18, France. E-mail: bruno.crestani{at}bch.ap-hop-paris.fr
Hepatocyte growth factor (HGF) is a growth factor that protects alveolar epithelial cells from pulmonary fibrosis in various animal models. We compared in vitro HGF production by human lung fibroblasts from patients with idiopathic pulmonary fibrosis (IPF, n = 8) and from control subjects (n = 6). Basal HGF secretion by IPF fibroblasts was decreased by 50% when compared with control fibroblasts (p < 0.05). HGF was secreted mainly in the cleaved mature form, both in IPF and control fibroblasts. HGF messenger RNA levels were reduced in IPF fibroblasts. Prostaglandin (PG) E2 secretion by IPF fibroblasts was low when compared with control subjects (p < 0.05). After the addition of PGE2 (10-6 M) or dibutyryl cyclic AMP (10-3 M), HGF secretion by IPF fibroblasts reached the level of control subjects. Inhibition of PGE2 synthesis with indomethacin reduced HGF secretion by control fibroblasts but had no effect on IPF fibroblasts. HGF secretion by control fibroblasts was also slightly inhibited by transforming growth factor (TGF)-ß1 and stimulated by antiTGF-ß antibody, whereas both agents had no effect on IPF fibroblasts. Our results demonstrate a defect in HGF production by IPF fibroblasts that seems secondary to a defect in PGE2 secretion.
Key Words: indomethacin pulmonary alveoli transforming growth factor ß usual interstitial pneumonia
This article has been cited by other articles:

|
 |

|
 |
 
S. K. Huang and M. Peters-Golden
Eicosanoid Lipid Mediators in Fibrotic Lung Diseases: Ready for Prime Time?
Chest,
June 1, 2008;
133(6):
1442 - 1450.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R Borie, A Fabre, F Prost, J Marchal-Somme, R Lebtahi, S Marchand-Adam, M Aubier, P Soler, and B Crestani
Activation of somatostatin receptors attenuates pulmonary fibrosis
Thorax,
March 1, 2008;
63(3):
251 - 258.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Quesnel, S. Marchand-Adam, A. Fabre, J. Marchal-Somme, I. Philip, S. Lasocki, V. Lecon, B. Crestani, and M. Dehoux
Regulation of hepatocyte growth factor secretion by fibroblasts in patients with acute lung injury
Am J Physiol Lung Cell Mol Physiol,
February 1, 2008;
294(2):
L334 - L343.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Gazdhar, P. Fachinger, C. van Leer, J. Pierog, M. Gugger, R. Friis, R. A. Schmid, and T. Geiser
Gene transfer of hepatocyte growth factor by electroporation reduces bleomycin-induced lung fibrosis
Am J Physiol Lung Cell Mol Physiol,
February 1, 2007;
292(2):
L529 - L536.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. Koli, M. Myllarniemi, K. Vuorinen, K. Salmenkivi, M. J. Ryynanen, V. L. Kinnula, and J. Keski-Oja
Bone Morphogenetic Protein-4 Inhibitor Gremlin Is Overexpressed in Idiopathic Pulmonary Fibrosis
Am. J. Pathol.,
July 1, 2006;
169(1):
61 - 71.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Marchand-Adam, A. Fabre, A. A. Mailleux, J. Marchal, C. Quesnel, H. Kataoka, M. Aubier, M. Dehoux, P. Soler, and B. Crestani
Defect of Pro-Hepatocyte Growth Factor Activation by Fibroblasts in Idiopathic Pulmonary Fibrosis
Am. J. Respir. Crit. Care Med.,
July 1, 2006;
174(1):
58 - 66.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Cohen, S. Marchand-Adam, V. Lecon-Malas, J. Marchal-Somme, A. Boutten, G. Durand, B. Crestani, and M. Dehoux
HGF synthesis in human lung fibroblasts is regulated by oncostatin M
Am J Physiol Lung Cell Mol Physiol,
June 1, 2006;
290(6):
L1097 - L1103.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Marchand-Adam, L. Plantier, D. Bernuau, A. Legrand, M. Cohen, J. Marchal, P. Soler, G. Leseche, H. Mal, M. Aubier, et al.
Keratinocyte Growth Factor Expression by Fibroblasts in Pulmonary Fibrosis: Poor Response to Interleukin-1{beta}
Am. J. Respir. Cell Mol. Biol.,
May 1, 2005;
32(5):
470 - 477.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. Plantier, S. Marchand-Adam, J. Marchal-Somme, G. Leseche, M. Fournier, M. Dehoux, M. Aubier, and B. Crestani
Defect of hepatocyte growth factor production by fibroblasts in human pulmonary emphysema
Am J Physiol Lung Cell Mol Physiol,
April 1, 2005;
288(4):
L641 - L647.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. S. White, R. G. Atrasz, E. G. Dickie, D. M. Aronoff, V. Stambolic, T. W. Mak, B. B. Moore, and M. Peters-Golden
Prostaglandin E2 Inhibits Fibroblast Migration by E-Prostanoid 2 Receptor-Mediated Increase in PTEN Activity
Am. J. Respir. Cell Mol. Biol.,
February 1, 2005;
32(2):
135 - 141.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. J. Hodges, R. G. Jenkins, C. P.D. Wheeler-Jones, D. M. Copeman, S. E. Bottoms, G. J. Bellingan, C. B. Nanthakumar, G. J. Laurent, S. L. Hart, M. L. Foster, et al.
Severity of Lung Injury in Cyclooxygenase-2-Deficient Mice Is Dependent on Reduced Prostaglandin E2 Production
Am. J. Pathol.,
November 1, 2004;
165(5):
1663 - 1676.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. J. Tobin
Tuberculosis, Lung Infections, Interstitial Lung Disease, Social Issues and Journalology in AJRCCM 2003
Am. J. Respir. Crit. Care Med.,
January 15, 2004;
169(2):
288 - 300.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Peters-Golden
When Defenses against Fibroproliferation Fail: Spotlight on an Axis of Prophylaxis
Am. J. Respir. Crit. Care Med.,
November 15, 2003;
168(10):
1141 - 1142.
[Full Text]
[PDF]
|
 |
|
Copyright © 2003 American Thoracic Society
|
|
|